|
Market Closed -
TEL AVIV STOCK EXCHANGE
07:54:24 15/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,435.00 ILa | +3.62% |
|
+0.70% | +7.74% |
| 06/10 | Kamada Launches Ustekinumab, Enoxaparin Biosimilars in Israel | MT |
| 06/10 | Kamada Ltd. Announces Expansion of Biosimilars Portfolio with Launch of Two Additional Products in Israel | CI |
| Market Cap | 140.52Cr 0 45Cr 40Cr 38Cr 34Cr 64Cr 4.29TCr 65Cr 451.26Cr 176.56Cr 2.24TCr 169.94Cr 166.34Cr 7.16TCr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 140.52Cr 0 45Cr 40Cr 38Cr 34Cr 64Cr 4.29TCr 65Cr 451.26Cr 176.56Cr 2.24TCr 169.94Cr 166.34Cr 7.16TCr | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 2.05x |
| Free-Float |
54.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| KMDA | Delayed | |
Nasdaq
| KMDA | Delayed | |
|
CBOE
| KMDA | Real-time |
Last Transcript: Kamada Ltd.
| 1 day | +3.62% | ||
| 1 week | +0.70% | ||
| Current month | -8.11% | ||
| 1 month | -2.79% | ||
| 3 months | +11.95% | ||
| 6 months | -4.77% | ||
| Current year | +7.74% |
| 1 week | 2,300 |  | 2,491 |
| 1 month | 2,300 | | 2,698 |
| Current year | 2,013 | | 2,890 |
| 1 year | 1,956 | | 2,890 |
| 3 years | 1,685 | | 3,045 |
| 5 years | 1,309 | | 3,045 |
| 10 years | 1,309 | | 4,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 58 | 01/07/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 56 | 31/12/2017 |
Eran Nir
COO | Chief Operating Officer | 54 | 01/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 13/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 07/03/2013 |
| Chairman | 55 | 12/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/09/26 | Exercice | VP Quality | 61,323 | 0.1063% | ||
| 14/09/26 | Sell | Founder | -22,827 | 0.0396% | ||
| 14/09/26 | Exercice | General Counsel | 23,459 | 0.0407% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.62% | +0.70% | +7.27% | +25.90% | 44Cr | |
| +3.55% | +7.01% | +51.42% | +102.97% | 1,07700Cr | |
| -0.25% | -1.25% | +32.49% | +60.78% | 61TCr | |
| +0.59% | +4.03% | +25.28% | +92.49% | 50TCr | |
| -1.48% | +1.97% | +72.62% | +39.42% | 36TCr | |
| +2.37% | +5.47% | +32.67% | +48.87% | 35TCr | |
| +2.64% | +4.90% | +21.01% | +43.85% | 28TCr | |
| +3.24% | +4.25% | -0.31% | +15.71% | 25TCr | |
| +1.86% | +6.53% | +45.98% | +51.29% | 23TCr | |
| +2.49% | +6.98% | +33.03% | +98.70% | 19TCr | |
| Average | +1.93% | +1.49% | +32.14% | +58.00% | 38.57TCr | |
| Weighted average by Cap. | +1.73% | +1.58% | +38.51% | +70.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61Cr 0 20Cr 18Cr 16Cr 15Cr 28Cr 1.86TCr 28Cr 195.41Cr 76Cr 969.06Cr 74Cr 72Cr 3.1TCr | 69Cr 0 22Cr 20Cr 18Cr 17Cr 31Cr 2.09TCr 32Cr 220.1Cr 86Cr 1.09TCr 83Cr 81Cr 3.49TCr |
| Net income | 8.34Cr 0 2.69Cr 2.4Cr 2.23Cr 2.03Cr 3.81Cr 254.51Cr 3.88Cr 27Cr 10Cr 132.79Cr 10Cr 9.87Cr 424.92Cr | 10Cr 0 3.26Cr 2.91Cr 2.71Cr 2.46Cr 4.64Cr 309.24Cr 4.72Cr 33Cr 13Cr 161.35Cr 12Cr 12Cr 516.3Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | ILA 2,435.00 | +3.62% | 89,797 |
| 14/26/14 | ILA 2,350.00 | -1.34% | 40,153 |
| 13/26/13 | ILA 2,382.00 | -2.14% | 44,934 |
| 12/26/12 | ILA 2,434.00 | -1.38% | 38,487 |
| 09/26/09 | ILA 2,468.00 | +4.05% | 63,555 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KMDA Stock
Select your edition
All financial news and data tailored to specific country editions
